(lp0
S'RGLS INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a ... Business Wire  - Feb 6, 2017 NEW YORK----The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of California on behalf of investors who purchased Regulus Therapeutics Inc.'
p1
aS'Regulus Therapeutics Inc.  Plunges 7.84% on March 20 Equities.com - 7 hours ago Regulus Therapeutics Inc.  had a rough trading day for Monday March 20 as shares tumbled 7.84%, or a loss of $-0.1 per share, to close at $1.18.'
p2
aS"A Look at 2 Trending Stocks: Regulus Therapeutics Inc. , CVR Refining ... Post Analyst - 16 hours ago The company's consensus rating on Reuter's scale improved from 2.9 to 3 during a month. Analysts set a 12-month price target of $11.35 a share."
p3
aS'IMPORTANT REGULUS THERAPEUTICS INC. INVESTOR ALERT: Wolf Haldenstein Adler ... GlobeNewswire  - Feb 9, 2017 NEW YORK and SAN DIEGO, Feb. 09, 2017  -- Wolf Haldenstein Adler Freeman &amp; Herz LLP announces that a class action lawsuit has been filed against Regulus Therapeutics Inc.   in the&nbsp;...'
p4
aS"Regulus Therapeutics Inc.  Plunges 7.14% on March 15 Equities.com - Mar 15, 2017 Regulus Therapeutics Inc.  had a rough trading day for Wednesday March 15 as shares tumbled 7.14%, or a loss of $-0.1 per share, to close at $1.30.Sell-Side Analyst's Predictions: Regulus Therapeutics Inc. , RH  - The USA Commerce"
p5
aS"Analysts Mixed On Two Volatile Stocks: CymaBay Therapeutics Inc (CBAY ... Smarter Analyst - Jan 30, 2017 Today was an explosive day in the biotech-verse as CymaBay Therapeutics Inc  shot up on back of H.C. Wainwright's upgrade and Regulus Therapeutics Inc  crashed under FDA's extended clinical hold of its key HCV&nbsp;...Regulus Therapeutics, Inc.  Receives FDA Notice  Shares drop 20% - StockNewsUnion"
p6
aS'RGLS SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a ... PR Newswire  - Mar 13, 2017 NEW YORK, March 13, 2017 /PRNewswire/ -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of California on behalf of investors who purchased Regulus Therapeutics Inc.'
p7
aS'Regulus Therapeutics Inc.  Soars 13.04% on March 08 Equities.com - Mar 8, 2017 Regulus Therapeutics Inc.  had a good day on the market for Wednesday March 08 as shares jumped 13.04% to close at $1.30.Regulus Therapeutics Inc.  Files Form 4 Insider Buying : William H ... - Energy IndexRegulus Therapeutics Inc.  added to 9 new portfolios - Post Analyst'
p8
aS"Regulus Reports Fourth Quarter 2016 Financial Results and Pipeline Update PR Newswire  - Mar 2, 2017 LA JOLLA, Calif., March 2, 2017 /PRNewswire/ -- Regulus Therapeutics Inc. , a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today reported financial results for the fourth&nbsp;...Analyst Activity  Cantor Fitzgerald Reiterates Buy on Regulus Therapeutics ... - Market ExclusiveRegulus Therapeutics'  CEO Paul Grint on Q4 2016 Results - Earnings Call ... - Seeking Alpha"
p9
aS'SHAREHOLDER ALERT: Khang &amp; Khang LLP Announces Securities Class Action Lawsuit ... Yahoo Finance - 14 hours ago IRVINE, CA / ACCESSWIRE / March 20, 2017 / Khang &amp; Khang LLP  announces the filing of a class action lawsuit against Regulus Therapeutics Inc.  . Investors, who purchased or otherwise acquired&nbsp;...'
p10
a.